Cargando…
NPAS3 variants in schizophrenia: a neuroimaging study
BACKGROUND: This research is a one-site neuroimaging component of a two-site genetic study involving patients with schizophrenia at early and later stages of illness. Studies support a role for the neuronal Per-Arnt-Sim 3 (NPAS3) gene in processes that are essential for normal brain development. Spe...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986669/ https://www.ncbi.nlm.nih.gov/pubmed/24674381 http://dx.doi.org/10.1186/1471-2350-15-37 |
_version_ | 1782311752024719360 |
---|---|
author | Bernier, Denise Macintyre, Georgina Bartha, Robert Hanstock, Christopher C McAllindon, David Cox, Diane Purdon, Scot Aitchison, Katherine J Rusak, Benjamin Tibbo, Philip G |
author_facet | Bernier, Denise Macintyre, Georgina Bartha, Robert Hanstock, Christopher C McAllindon, David Cox, Diane Purdon, Scot Aitchison, Katherine J Rusak, Benjamin Tibbo, Philip G |
author_sort | Bernier, Denise |
collection | PubMed |
description | BACKGROUND: This research is a one-site neuroimaging component of a two-site genetic study involving patients with schizophrenia at early and later stages of illness. Studies support a role for the neuronal Per-Arnt-Sim 3 (NPAS3) gene in processes that are essential for normal brain development. Specific NPAS3 variants have been observed at an increased frequency in schizophrenia. In humans, NPAS3 protein was detected in the hippocampus from the first trimester of gestation. In addition, NPAS3 protein levels were reduced in the dorsolateral prefrontal cortex of some patients with schizophrenia. Npas3 knockout mice display behavioural, neuroanatomical and structural changes with associated severe reductions in neural precursor cell proliferation in the hippocampal dentate gyrus. This study will evaluate the hypothesis that the severe reductions in neural precursor cell proliferation in the dentate gyrus will be present to some degree in patients carrying schizophrenia-associated NPAS3 variants and less so in other patients. METHODS/DESIGN: Patients enrolled in the larger genetic study (n = 150) will be invited to participate in this neuroimaging arm. The genetic data will be used to ensure a sample size of 45 participants in each genetic subgroup of patients (with and without NPAS3 variants). In addition, we will recruit 60 healthy controls for acquisition of normative data. The following neuroimaging measures will be acquired from the medial temporal region: a) an index of the microcellular environment; b) a macro-structural volumetric measure of the hippocampus; and c) concentration levels of N-acetylaspartate, a marker of neuronal health. DISCUSSION: This study will help to establish the contribution of the NPAS3 gene and its variants to brain tissue abnormalities in schizophrenia. Given the genetic and phenotypic heterogeneity of the disorder and the large variation in outcomes, the identification of biological subgroups may in future support tailoring of treatment approaches in order to optimize recovery. |
format | Online Article Text |
id | pubmed-3986669 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39866692014-04-16 NPAS3 variants in schizophrenia: a neuroimaging study Bernier, Denise Macintyre, Georgina Bartha, Robert Hanstock, Christopher C McAllindon, David Cox, Diane Purdon, Scot Aitchison, Katherine J Rusak, Benjamin Tibbo, Philip G BMC Med Genet Study Protocol BACKGROUND: This research is a one-site neuroimaging component of a two-site genetic study involving patients with schizophrenia at early and later stages of illness. Studies support a role for the neuronal Per-Arnt-Sim 3 (NPAS3) gene in processes that are essential for normal brain development. Specific NPAS3 variants have been observed at an increased frequency in schizophrenia. In humans, NPAS3 protein was detected in the hippocampus from the first trimester of gestation. In addition, NPAS3 protein levels were reduced in the dorsolateral prefrontal cortex of some patients with schizophrenia. Npas3 knockout mice display behavioural, neuroanatomical and structural changes with associated severe reductions in neural precursor cell proliferation in the hippocampal dentate gyrus. This study will evaluate the hypothesis that the severe reductions in neural precursor cell proliferation in the dentate gyrus will be present to some degree in patients carrying schizophrenia-associated NPAS3 variants and less so in other patients. METHODS/DESIGN: Patients enrolled in the larger genetic study (n = 150) will be invited to participate in this neuroimaging arm. The genetic data will be used to ensure a sample size of 45 participants in each genetic subgroup of patients (with and without NPAS3 variants). In addition, we will recruit 60 healthy controls for acquisition of normative data. The following neuroimaging measures will be acquired from the medial temporal region: a) an index of the microcellular environment; b) a macro-structural volumetric measure of the hippocampus; and c) concentration levels of N-acetylaspartate, a marker of neuronal health. DISCUSSION: This study will help to establish the contribution of the NPAS3 gene and its variants to brain tissue abnormalities in schizophrenia. Given the genetic and phenotypic heterogeneity of the disorder and the large variation in outcomes, the identification of biological subgroups may in future support tailoring of treatment approaches in order to optimize recovery. BioMed Central 2014-03-27 /pmc/articles/PMC3986669/ /pubmed/24674381 http://dx.doi.org/10.1186/1471-2350-15-37 Text en Copyright © 2014 Bernier et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol Bernier, Denise Macintyre, Georgina Bartha, Robert Hanstock, Christopher C McAllindon, David Cox, Diane Purdon, Scot Aitchison, Katherine J Rusak, Benjamin Tibbo, Philip G NPAS3 variants in schizophrenia: a neuroimaging study |
title | NPAS3 variants in schizophrenia: a neuroimaging study |
title_full | NPAS3 variants in schizophrenia: a neuroimaging study |
title_fullStr | NPAS3 variants in schizophrenia: a neuroimaging study |
title_full_unstemmed | NPAS3 variants in schizophrenia: a neuroimaging study |
title_short | NPAS3 variants in schizophrenia: a neuroimaging study |
title_sort | npas3 variants in schizophrenia: a neuroimaging study |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986669/ https://www.ncbi.nlm.nih.gov/pubmed/24674381 http://dx.doi.org/10.1186/1471-2350-15-37 |
work_keys_str_mv | AT bernierdenise npas3variantsinschizophreniaaneuroimagingstudy AT macintyregeorgina npas3variantsinschizophreniaaneuroimagingstudy AT bartharobert npas3variantsinschizophreniaaneuroimagingstudy AT hanstockchristopherc npas3variantsinschizophreniaaneuroimagingstudy AT mcallindondavid npas3variantsinschizophreniaaneuroimagingstudy AT coxdiane npas3variantsinschizophreniaaneuroimagingstudy AT purdonscot npas3variantsinschizophreniaaneuroimagingstudy AT aitchisonkatherinej npas3variantsinschizophreniaaneuroimagingstudy AT rusakbenjamin npas3variantsinschizophreniaaneuroimagingstudy AT tibbophilipg npas3variantsinschizophreniaaneuroimagingstudy |